Squamous intraepithelial lesions (SIL) is a
term that refers to abnormal changes in the cells
on the surface of the cervix.
- squamous cells are the flat cells found
on the surface (of the cervix)
- intraepithelial means that the abnormal
cells are present only in the surface layer
of cells
- lesion refers to an area of abnormal tissue
According to the National Cancer Institute (NCI),
changes in these cells can be divided into two
categories:
- Low-grade SIL refers to early changes in
the size, shape, and number of cells that form
the surface of the cervix. They may go away
on their own, or, with time, may grow larger
or become more abnormal, forming a high-grade
lesion.
These precancerous low-grade lesions may also
be called mild dysplasia or cervical intraepithelial
neoplasia 1 (CIN 1). These early changes most
often occur in women between the ages of 25 and
35, but can appear at any age.
- High-grade SIL means there are a large number
of precancerous cells, and, like low-grade
SIL, these precancerous changes involve only
cells on the surface of the cervix. The cells
often do not become cancerous for many months,
sometimes years.
High-grade lesions may also be called moderate
or severe dysplasia, CIN 2 or 3, or carcinoma
in situ. They develop most often in women between
the ages of 30 and 40, but can occur at any age.
What
is cancer of the cervix?
If abnormal cells on the surface of the cervix
spread deeper into the cervix, or to other tissues
or organs, the disease is then called cervical
cancer, or invasive cervical cancer. Cervical
cancer occurs most often in women over the age
of 40. It is different from cancer that begins
in other parts of the uterus and requires different
treatment. Most cervical cancers are squamous
cell carcinomas and adenocarcinomas.
The mortality rates for cervical cancer have
declined sharply as Pap screenings have become
more prevalent. Some researchers estimate that
noninvasive cervical cancer (also referred to
as "carcinoma in situ") is nearly four
times more common than invasive cervical cancer.
Chlamydia and Cervical Cancer
New research has shown that chlamydia, the most
common sexually transmitted disease in the US,
may increase a woman's risk of developing cervical
cancer. In the study, published in the Journal
of the American Medical Association (JAMA), women
who showed signs of any type of chlamydial infection
in their blood were two-and-a-half times more
likely to develop cervical cancer, when compared
to women with no sign of infection. Although
the reason for this increased risk is still under
investigation, researchers speculate that immune
system cells that are activated at chlamydia
infection sites may damage normal cells.
What are the risk factors for cervical cancer?
The following have been suggested as risk factors
for cervical cancer:
- Infection with the human papillomavirus
(HPV)
- Infection with the human immunodeficiency
virus (HIV) or other conditions that weaken
the immune system
- Smoking- Women who smoke are nearly twice
as likely as nonsmokers to have cervical cancer.
- Age- The risk of cancer of the cervix increases
between the late teens and mid-30s. However,
cervical cancer can occur at any age.
- Having sexual intercourse before the age
of 18
- Having many sexual partners, and having
partners who have had sexual intercourse at
a young age and/or have had many partners themselves
Can
cervical cancer be prevented?
With the recent development of a vaccine to
prevent infection with Human Papilloma Virus
(HPV), the fight against cervical cancer has
taken a giant leap forward. HPV infection, one
of the most common sexually transmitted diseases,
has been linked to the development of both cervical
cancer and genital warts.
Approved by the Food and Drug Administration,
the HPV vaccine provides immunity to four different
types of HPV which, combined, account for approximatley
70 percent of all cervical cancers, 60 percent
of pre-cancerous lesions, and more than 90 percent
of genital warts. The vaccine is administered
as three injections given over a six month period.
It appears to be safe and well-tolerated. In
each of four studies, the vaccine was found to
be 100 percent effective. It is recommended for
girls and women aged nine to 26 for the prevention
of both genital warts and cervical cancer caused
by HPV. It is not recommended for the treatment
of active disease. Studies for the use of the
vaccine in males are ongoing. The vaccine works
best if administered before contact with HPV
but can be given without being tested for the
virus.
Still, early detection of cervical problems
is the best way to prevent cervical cancer.
The Pap test, which is performed as part of
a regular gynecological check-up, is a screening
test for abnormalities of the cervix. It is a
simple, painless test where cells are wiped from
the cervix and sent to a laboratory to be examined
under a microscope. Routine, annual pelvic examinations
and Pap tests can detect precancerous conditions
that often can be treated before cancer develops.
Women who are or have been sexually active, or
are age 18 or older, should have regular checkups,including
a pelvic exam and Pap test.
What
are the symptoms of cervical cancer?
Symptoms of cervical cancer usually do not appear
until abnormal cervical cells become cancerous
and invade nearby tissue.
The most common symptom is abnormal bleeding,
which may:
The symptoms of cervical cancer may resemble
other conditions or medical problems. Consult
a physician for diagnosis.
How
is cervical cancer diagnosed?
When cervical problems are found during a pelvic
examination, or abnormal cells are found through
a Pap test, a cervical biopsy may be performed.
There are several types of cervical biopsies
that may be used to diagnose cervical cancer,
and some of these procedures that can completely
remove areas of abnormal tissue may also be used
for treatment of precancerous lesions. Some biopsy
procedures only require local anesthesia, while
others require a general anesthesia. Several
types of cervical biopsies include:
- loop electrosurgical excision procedure
(LEEP) - a procedure which uses
an electric wire loop to obtain a piece of
tissue.
- colposcopy - a procedure
which uses an instrument with magnifying lenses,
called a colposcope, to examine the cervix
for abnormalities. If abnormal tissue is found,
a biopsy is usually performed (colposcopic
biopsy).
- endocervical curettage (ECC) -
a procedure which uses a narrow instrument
called a curette to scrape the lining of the
endocervical canal. This type of biopsy is
usually completed along with the colposcopic
biopsy.
- cone biopsy (also called conization) -
a biopsy in which a larger cone-shaped piece
of tissue is removed from the cervix by using
the loop electrosurgical excision procedure
or the cold knife cone biopsy procedure. The
cone biopsy procedure may be used as a treatment
for precancerous lesions and early cancers.
- cold knife cone biopsy -
a procedure in which a laser or a surgical
scalpel is used to remove a piece of tissue.
This procedure requires the use of general
anesthesia.
Treatment
for cervical cancer:
Specific treatment for cervical cancer will
be determined by your physician based on:
- your overall health and medical history
- extent of the disease
- your tolerance for specific medications,
procedures, or therapies
- expectations for the course of the disease
- your opinion or preference
Treatment may include:
LEEP or conization may also be used to remove
abnormal tissue.
The most important factor in the early
detection of cervical cancer is continued surveillance
with a regular schedule of Pap tests as recommended
by your doctor.
|